Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models
by
Schmidt, Heath D
, Duman, Ronald S
in
Animals
/ Anti-Anxiety Agents - metabolism
/ Anti-Anxiety Agents - pharmacology
/ Anti-Anxiety Agents - therapeutic use
/ Antidepressive Agents - metabolism
/ Antidepressive Agents - pharmacology
/ Antidepressive Agents - therapeutic use
/ Anxiety - drug therapy
/ Brain-Derived Neurotrophic Factor - administration & dosage
/ Brain-Derived Neurotrophic Factor - metabolism
/ Brain-Derived Neurotrophic Factor - pharmacology
/ Brain-Derived Neurotrophic Factor - therapeutic use
/ Corpus Striatum - drug effects
/ Corpus Striatum - metabolism
/ Cyclic AMP Response Element-Binding Protein - metabolism
/ Depression - drug therapy
/ Disease Models, Animal
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Hippocampus - drug effects
/ Hippocampus - metabolism
/ Infusions, Subcutaneous
/ Male
/ Mice
/ Mice, Inbred BALB C
/ Mice, Inbred C57BL
/ Neurogenesis - drug effects
/ Original
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - metabolism
/ Recombinant Proteins - pharmacology
/ Recombinant Proteins - therapeutic use
2010
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models
by
Schmidt, Heath D
, Duman, Ronald S
in
Animals
/ Anti-Anxiety Agents - metabolism
/ Anti-Anxiety Agents - pharmacology
/ Anti-Anxiety Agents - therapeutic use
/ Antidepressive Agents - metabolism
/ Antidepressive Agents - pharmacology
/ Antidepressive Agents - therapeutic use
/ Anxiety - drug therapy
/ Brain-Derived Neurotrophic Factor - administration & dosage
/ Brain-Derived Neurotrophic Factor - metabolism
/ Brain-Derived Neurotrophic Factor - pharmacology
/ Brain-Derived Neurotrophic Factor - therapeutic use
/ Corpus Striatum - drug effects
/ Corpus Striatum - metabolism
/ Cyclic AMP Response Element-Binding Protein - metabolism
/ Depression - drug therapy
/ Disease Models, Animal
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Hippocampus - drug effects
/ Hippocampus - metabolism
/ Infusions, Subcutaneous
/ Male
/ Mice
/ Mice, Inbred BALB C
/ Mice, Inbred C57BL
/ Neurogenesis - drug effects
/ Original
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - metabolism
/ Recombinant Proteins - pharmacology
/ Recombinant Proteins - therapeutic use
2010
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models
by
Schmidt, Heath D
, Duman, Ronald S
in
Animals
/ Anti-Anxiety Agents - metabolism
/ Anti-Anxiety Agents - pharmacology
/ Anti-Anxiety Agents - therapeutic use
/ Antidepressive Agents - metabolism
/ Antidepressive Agents - pharmacology
/ Antidepressive Agents - therapeutic use
/ Anxiety - drug therapy
/ Brain-Derived Neurotrophic Factor - administration & dosage
/ Brain-Derived Neurotrophic Factor - metabolism
/ Brain-Derived Neurotrophic Factor - pharmacology
/ Brain-Derived Neurotrophic Factor - therapeutic use
/ Corpus Striatum - drug effects
/ Corpus Striatum - metabolism
/ Cyclic AMP Response Element-Binding Protein - metabolism
/ Depression - drug therapy
/ Disease Models, Animal
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Hippocampus - drug effects
/ Hippocampus - metabolism
/ Infusions, Subcutaneous
/ Male
/ Mice
/ Mice, Inbred BALB C
/ Mice, Inbred C57BL
/ Neurogenesis - drug effects
/ Original
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - metabolism
/ Recombinant Proteins - pharmacology
/ Recombinant Proteins - therapeutic use
2010
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models
Journal Article
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models
2010
Request now
and choose the collection method
Overview
Recent clinical studies demonstrate that serum levels of brain-derived neurotrophic factor (BDNF) are significantly decreased in patients with major depressive disorder (MDD) and that antidepressant treatments reverse this effect, indicating that serum BDNF is a biomarker of MDD. These findings raise the possibility that serum BDNF may also have effects on neuronal activity and behavior, but the functional significance of altered serum BDNF is unknown. To address this issue, we determined the influence of peripheral BDNF administration on depression- and anxiety-like behavior, including the forced swim test (FST), chronic unpredictable stress (CUS)/anhedonia, novelty-induced hypophagia (NIH) test, and elevated-plus maze (EPM). Furthermore, we examined adult hippocampal neurogenesis as well as hippocampal and striatal expression of BDNF, extracellular signal-regulated kinase (ERK) and cAMP response element-binding protein (CREB), in order to determine whether peripherally administered BDNF produces antidepressant-like cellular responses in the brain. Peripheral BDNF administration increased mobility in the FST, attenuated the effects of CUS on sucrose consumption, decreased latency in the NIH test, and increased time spent in the open arms of an EPM. Moreover, adult hippocampal neurogenesis was increased after chronic, peripheral BDNF administration. We also found that BDNF levels as well as expression of pCREB and pERK were elevated in the hippocampus of adult mice receiving peripheral BDNF. Taken together, these results indicate that peripheral/serum BDNF may not only represent a biomarker of MDD, but also have functional consequences on molecular signaling substrates, neurogenesis, and behavior.
Publisher
Nature Publishing Group
Subject
/ Anti-Anxiety Agents - metabolism
/ Anti-Anxiety Agents - pharmacology
/ Anti-Anxiety Agents - therapeutic use
/ Antidepressive Agents - metabolism
/ Antidepressive Agents - pharmacology
/ Antidepressive Agents - therapeutic use
/ Brain-Derived Neurotrophic Factor - administration & dosage
/ Brain-Derived Neurotrophic Factor - metabolism
/ Brain-Derived Neurotrophic Factor - pharmacology
/ Brain-Derived Neurotrophic Factor - therapeutic use
/ Corpus Striatum - drug effects
/ Corpus Striatum - metabolism
/ Cyclic AMP Response Element-Binding Protein - metabolism
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Male
/ Mice
/ Original
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - metabolism
This website uses cookies to ensure you get the best experience on our website.